A computational DNA methylation method to remove contaminated DNA from spent embryo culture medium for noninvasive preimplantation genetic testing.

IF 9.7 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Yidong Chen, Jin Huang, Fuchou Tang, Lu Wen, Jie Qiao
{"title":"A computational DNA methylation method to remove contaminated DNA from spent embryo culture medium for noninvasive preimplantation genetic testing.","authors":"Yidong Chen, Jin Huang, Fuchou Tang, Lu Wen, Jie Qiao","doi":"10.1016/j.ebiom.2025.105669","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the last fifty years, assisted reproductive technology (ART) has achieved remarkable breakthroughs, culminating in the birth of 12 million infants. At the heart of ART success is preimplantation genetic testing (PGT), which enables the detection of chromosomal anomalies, single-gene disorders, and structural rearrangements, enhancing embryo selection and mitigating genetic risk. However, current PGT methods, including trophectoderm (TE) biopsy, face limitations such as challenges related to convenience and potential impacts on embryonic health. In this evolving field, noninvasive PGT (niPGT) has emerged as a promising alternative. By analysing cell-free DNA (cfDNA) in spent embryo culture medium (SECM), niPGT offers a less intrusive approach. However, maternal DNA contamination within SECM remains a marked barrier to its clinical application as underscored by our research and other studies. There is an urgent need for innovation and optimisation in niPGT methodologies.</p><p><strong>Methods: </strong>We developed a computational algorithm to eliminate contaminated nonembryonic DNA from spent embryo culture medium. The rationale is based on the phenomenon that the DNA methylation level of a mammalian preimplantation embryo reaches its minimum at the blastocyst stage during a global DNA demethylation wave. Therefore, selecting hypomethylated reads is expected to enrich blastocyst DNA over nonembryonic DNA. To investigate this, we retrieved single-cell-resolution DNA methylation data from oocytes (n = 33), inner cell masses (ICMs, n = 74), TEs (n = 71) and sperm cells (n = 21), bulk DNA methylation data from cumulus cells, and DNA methylation data from SECM samples (n = 194) from our previously published database, and conducted a comparative analysis of DNA methylation patterns among them. Then, we constructed a decontamination algorithm based on single read and applied it to remove contamination originating from cumulus cells, polar bodies, and sperm cells.</p><p><strong>Findings: </strong>By selecting hypomethylated reads, we successfully enriched blastocyst DNA over DNA originating from cumulus cells, polar bodies and sperm (enrichment factors = 4, 1.2, and 2.5, respectively). By testing simulated SECM samples, the method demonstrated a substantial reduction in the false-negative rate even with up to 75% cumulus cell contamination. In real clinical SECM samples, the method improved aneuploidy detection sensitivity at a cumulus cell contamination ratio of 50%.</p><p><strong>Interpretation: </strong>Our study introduces a novel computational strategy for reducing nonembryonic DNA contamination, thereby enhancing aneuploidy detection sensitivity in SECM cfDNA methylation analyses. In combination with DNA methylation methodologies, this approach holds considerable promise for advancing niPGT applications in ART.</p><p><strong>Funding: </strong>This study was supported by grants from the Beijing Natural Science Foundation (7232203), the National Key R&D Program of China (2023YFC2705600, 2023YFC2705602), the National Natural Science Foundation of China (82301889, 82371706), the Key Clinical Projects of Peking University Third Hospital (BYSYZD2022029), the Young Elite Scientists Sponsorship Program by CAST (2023QNRC001), the Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation (BMU2023YFJHPY001) and the special fund of the National Clinical Key Specialty Construction Program, P. R. China (2023). We thank support from the High Performance Computing Platform of the Centre for Life Sciences (Peking University) and Open Research Fund of the National Centre for Protein Sciences at Peking University in Beijing.</p>","PeriodicalId":11494,"journal":{"name":"EBioMedicine","volume":"114 ","pages":"105669"},"PeriodicalIF":9.7000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EBioMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ebiom.2025.105669","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In the last fifty years, assisted reproductive technology (ART) has achieved remarkable breakthroughs, culminating in the birth of 12 million infants. At the heart of ART success is preimplantation genetic testing (PGT), which enables the detection of chromosomal anomalies, single-gene disorders, and structural rearrangements, enhancing embryo selection and mitigating genetic risk. However, current PGT methods, including trophectoderm (TE) biopsy, face limitations such as challenges related to convenience and potential impacts on embryonic health. In this evolving field, noninvasive PGT (niPGT) has emerged as a promising alternative. By analysing cell-free DNA (cfDNA) in spent embryo culture medium (SECM), niPGT offers a less intrusive approach. However, maternal DNA contamination within SECM remains a marked barrier to its clinical application as underscored by our research and other studies. There is an urgent need for innovation and optimisation in niPGT methodologies.

Methods: We developed a computational algorithm to eliminate contaminated nonembryonic DNA from spent embryo culture medium. The rationale is based on the phenomenon that the DNA methylation level of a mammalian preimplantation embryo reaches its minimum at the blastocyst stage during a global DNA demethylation wave. Therefore, selecting hypomethylated reads is expected to enrich blastocyst DNA over nonembryonic DNA. To investigate this, we retrieved single-cell-resolution DNA methylation data from oocytes (n = 33), inner cell masses (ICMs, n = 74), TEs (n = 71) and sperm cells (n = 21), bulk DNA methylation data from cumulus cells, and DNA methylation data from SECM samples (n = 194) from our previously published database, and conducted a comparative analysis of DNA methylation patterns among them. Then, we constructed a decontamination algorithm based on single read and applied it to remove contamination originating from cumulus cells, polar bodies, and sperm cells.

Findings: By selecting hypomethylated reads, we successfully enriched blastocyst DNA over DNA originating from cumulus cells, polar bodies and sperm (enrichment factors = 4, 1.2, and 2.5, respectively). By testing simulated SECM samples, the method demonstrated a substantial reduction in the false-negative rate even with up to 75% cumulus cell contamination. In real clinical SECM samples, the method improved aneuploidy detection sensitivity at a cumulus cell contamination ratio of 50%.

Interpretation: Our study introduces a novel computational strategy for reducing nonembryonic DNA contamination, thereby enhancing aneuploidy detection sensitivity in SECM cfDNA methylation analyses. In combination with DNA methylation methodologies, this approach holds considerable promise for advancing niPGT applications in ART.

Funding: This study was supported by grants from the Beijing Natural Science Foundation (7232203), the National Key R&D Program of China (2023YFC2705600, 2023YFC2705602), the National Natural Science Foundation of China (82301889, 82371706), the Key Clinical Projects of Peking University Third Hospital (BYSYZD2022029), the Young Elite Scientists Sponsorship Program by CAST (2023QNRC001), the Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation (BMU2023YFJHPY001) and the special fund of the National Clinical Key Specialty Construction Program, P. R. China (2023). We thank support from the High Performance Computing Platform of the Centre for Life Sciences (Peking University) and Open Research Fund of the National Centre for Protein Sciences at Peking University in Beijing.

一种从废胚培养基中去除污染DNA的计算DNA甲基化方法,用于无创植入前遗传学检测。
背景:在过去的50年里,辅助生殖技术(ART)取得了显著的突破,最终诞生了1200万婴儿。ART成功的核心是植入前基因检测(PGT),它能够检测染色体异常、单基因疾病和结构重排,加强胚胎选择并减轻遗传风险。然而,目前的PGT方法,包括滋养外胚层(TE)活检,面临着诸如便利性和对胚胎健康的潜在影响等方面的挑战。在这一不断发展的领域,无创PGT (niPGT)已成为一种有前途的替代方案。通过分析废胚培养基(SECM)中的无细胞DNA (cfDNA), niPGT提供了一种侵入性较小的方法。然而,正如我们的研究和其他研究所强调的那样,母体DNA污染在SECM中仍然是其临床应用的显着障碍。迫切需要创新和优化niPGT方法。方法:我们开发了一种从废胚培养基中去除受污染的非胚胎DNA的计算算法。其基本原理是基于这样一种现象,即哺乳动物着床前胚胎的DNA甲基化水平在囊胚阶段达到最低,而在整个DNA去甲基化波中。因此,选择低甲基化reads有望使胚泡DNA比非胚胎DNA更丰富。为了研究这一点,我们检索了来自卵母细胞(n = 33)、内细胞团(n = 74)、TEs (n = 71)和精子细胞(n = 21)的单细胞分辨率DNA甲基化数据,来自积云细胞的大量DNA甲基化数据,以及来自我们之前发表的数据库中的SECM样本(n = 194)的DNA甲基化数据,并对它们之间的DNA甲基化模式进行了比较分析。然后,我们构建了一种基于单读的去污算法,并将其应用于去除来自积云细胞、极体和精子细胞的污染。结果:通过选择低甲基化的reads,我们成功地在来自积云细胞、极体和精子的DNA上富集了囊胚DNA(富集因子分别为4、1.2和2.5)。通过测试模拟的SECM样品,该方法证明了即使在高达75%的积云细胞污染情况下,假阴性率也大大降低。在实际的临床SECM样品中,该方法在积云细胞污染率为50%时提高了非整倍体检测灵敏度。我们的研究引入了一种新的计算策略来减少非胚胎DNA污染,从而提高SECM cfDNA甲基化分析中的非整倍体检测灵敏度。结合DNA甲基化方法,这种方法对推进niPGT在ART中的应用具有相当大的希望。资助:北京市自然科学基金项目(7232203)、国家重点研发计划项目(2023YFC2705600、2023YFC2705602)、国家自然科学基金项目(82301889、82371706)、北京大学第三医院临床重点项目(BYSYZD2022029)、中国科研院青年精英科学家资助项目(2023QNRC001)、中国科研院项目(2023QNRC001)资助。北京大学医药启航青年学者科技创新项目(BMU2023YFJHPY001)和国家临床重点专科建设计划专项基金(2023)。我们感谢北京大学生命科学中心高性能计算平台和北京大学国家蛋白质科学中心开放研究基金的支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
EBioMedicine
EBioMedicine Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
CiteScore
17.70
自引率
0.90%
发文量
579
审稿时长
5 weeks
期刊介绍: eBioMedicine is a comprehensive biomedical research journal that covers a wide range of studies that are relevant to human health. Our focus is on original research that explores the fundamental factors influencing human health and disease, including the discovery of new therapeutic targets and treatments, the identification of biomarkers and diagnostic tools, and the investigation and modification of disease pathways and mechanisms. We welcome studies from any biomedical discipline that contribute to our understanding of disease and aim to improve human health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信